Cargando…

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

OBJECTIVES: High‐dose pulsed methylprednisolone‐related liver injury cases have been reported in the literature, but a prospective study in patients with multiple sclerosis (MS) has never been performed. The aim of this study was to evaluate the prevalence and severity of liver injury in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nociti, Viviana, Biolato, Marco, De Fino, Chiara, Bianco, Assunta, Losavio, Francesco Antonio, Lucchini, Matteo, Marrone, Giuseppe, Grieco, Antonio, Mirabella, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991562/ https://www.ncbi.nlm.nih.gov/pubmed/29729087 http://dx.doi.org/10.1002/brb3.968

Ejemplares similares

The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
por: Biolato, Marco, et al.
Publicado: (2021)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach
por: Cicia, Alessandra, et al.
Publicado: (2022)

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2022)

BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2018)

Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2019)

The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre
por: Lucchini, Matteo, et al.
Publicado: (2022)

Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments
por: Seddone, Silvia, et al.
Publicado: (2021)

Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach
por: Biolato, Marco, et al.
Publicado: (2017)

Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
por: Nociti, Viviana, et al.
Publicado: (2022)

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia
por: Biolato, Marco, et al.
Publicado: (2022)

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)

Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis
por: Biolato, Marco, et al.
Publicado: (2019)

Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI
por: Marrone, Giuseppe, et al.
Publicado: (2021)

Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI
por: Marrone, Giuseppe, et al.
Publicado: (2021)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
por: Bianco, Assunta, et al.
Publicado: (2021)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021)

Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
por: Giudiceandrea, Andrea, et al.
Publicado: (2018)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review
por: Carlomagno, Vincenzo, et al.
Publicado: (2023)

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
por: Capone, Fioravante, et al.
Publicado: (2021)

Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013)

The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study
por: Bientinesi, Riccardo, et al.
Publicado: (2022)

Disseminated intravascular coagulation after splenic artery aneurysm coils embolization: an unexpected surprise
por: Biolato, Marco, et al.
Publicado: (2023)

Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy
por: Miśkiewicz, Piotr, et al.
Publicado: (2018)

Multiple Sclerosis and Autoimmune Comorbidities
por: Nociti, Viviana, et al.
Publicado: (2022)

The Role of BDNF in Multiple Sclerosis Neuroinflammation
por: Nociti, Viviana, et al.
Publicado: (2023)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015)

Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017)

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
por: Singh Sehgal, Inderpaul, et al.
Publicado: (2014)

Effect of liver transplantation on intestinal permeability and correlation with infection episodes
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection
por: Sarriá-Landete, Antonio J., et al.
Publicado: (2022)

Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection
por: Sarriá-Landete, Antonio J., et al.
Publicado: (2022)

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019)

What do we know about the role of lncRNAs in multiple sclerosis?
por: Nociti, Viviana, et al.
Publicado: (2021)

The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review
por: Nociti, Viviana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f517t2oqacso0j0bi1vm6o3q3m